The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of genomic alterations with outcome in patients (pts) with urothelial carcinoma (UC).
 
Hamid Emamekhoo
No Relationships to Disclose
 
Monali K. Vasekar
No Relationships to Disclose
 
Monika Joshi
Consulting or Advisory Role - Bayer
 
Sierra Min Li
No Relationships to Disclose
 
Arnab Basu
No Relationships to Disclose
 
JoAnn Hsu
No Relationships to Disclose
 
Junjia Zhu
No Relationships to Disclose
 
Garrett Michael Frampton
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Siraj Mahamed Ali
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Vincent A. Miller
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Jeffrey S. Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jorge A. Garcia
Honoraria - Astellas Pharma; Bayer; GlaxoSmithKline; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; GlaxoSmithKline; Lpath; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; GlaxoSmithKline; Pfizer; Sanofi
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Aveo; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Petros Grivas
Consulting or Advisory Role - Bayer; Dendreon; Genentech
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst)